Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Key Stats

• Today's Range: $473.65 to $484.88
• 50-Day Range: $390.17 to $484.90
• 52-Week Range: $385.46 to $627.88
• Volume: 2.58 million shs
• Average Volume: 3.12 million shs
• Market Capitalization: $180.07 billion
• P/E Ratio: 27.59
• Dividend Yield: 0.36%
• Price Target: $593.00
• Consensus Rating: Moderate Buy

Thermo Fisher Scientific Stock Analysis - MarketRank™

Thermo Fisher Scientific scored higher than 99% of companies evaluated by MarketBeat, and ranked 20th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Thermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 15 buy ratings, 6 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Thermo Fisher Scientific has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 9.79%

Earnings Growth

Earnings for Thermo Fisher Scientific are expected to grow by 9.79% in the coming year, from $23.28 to $25.56 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Thermo Fisher Scientific is 27.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.75.

Price to Earnings Ratio vs. Sector

The P/E ratio of Thermo Fisher Scientific is 27.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.20.

Price to Earnings Growth Ratio

Thermo Fisher Scientific has a PEG Ratio of 2.58. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Thermo Fisher Scientific has a P/B Ratio of 3.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.17% of the float of Thermo Fisher Scientific has been sold short.

Short Interest Ratio / Days to Cover

Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Thermo Fisher Scientific has recently decreased by 10.18%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Thermo Fisher Scientific has a dividend yield of 0.36%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Thermo Fisher Scientific has been increasing its dividend for 8 years.

Dividend Coverage

The dividend payout ratio of Thermo Fisher Scientific is 9.95%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.73% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.1 / 5
• Environmental Score: -1.44

Percentage of Shares Shorted

1.17% of the float of Thermo Fisher Scientific has been sold short.

Short Interest Ratio / Days to Cover

Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Thermo Fisher Scientific has recently decreased by 10.18%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.95

News Sentiment

Thermo Fisher Scientific has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 95 news articles for Thermo Fisher Scientific this week, compared to 39 articles on an average week.

Search Interest

56 people have searched for TMO on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.

MarketBeat Follows

11 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 22% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $191,992.00 in company stock.

Percentage Held by Insiders

Only 0.33% of the stock of Thermo Fisher Scientific is held by insiders.

Percentage Held by Institutions

89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

TMO Stock Analysis - Frequently Asked Questions

How have TMO shares performed this year?

Thermo Fisher Scientific's stock was trading at $520.23 at the beginning of 2025. Since then, TMO stock has decreased by 8.3% and is now trading at $477.01.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) announced its quarterly earnings data on Wednesday, July, 23rd. The medical research company reported $5.36 EPS for the quarter, beating analysts' consensus estimates of $5.22 by $0.14. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year.
Read the conference call transcript.

Is Thermo Fisher Scientific doing a stock buyback?

Thermo Fisher Scientific's Board of Directors authorized a stock buyback plan on Friday, November 15th 2024, which permits the company to buy back $4,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 2% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board of directors believes its stock is undervalued.

Does Thermo Fisher Scientific have any subsidiaries?

Thermo Fisher Scientific subsidiaries include Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more.

Who are Thermo Fisher Scientific's major shareholders?

Top institutional investors of Thermo Fisher Scientific include Swedbank AB (0.45%), Vontobel Holding Ltd. (0.29%), Cantillon Capital Management LLC (0.23%) and Ninety One UK Ltd (0.21%). Insiders that own company stock include Marc N Casper, Stephen Williamson, Gianluca Pettiti, Jim P Manzi, Lisa P Britt, Michael A Boxer, Joseph R Holmes and Debora L Spar.
View institutional ownership trends.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include BlackRock (BLK), Broadcom (AVGO), UnitedHealth Group (UNH), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW) and NVIDIA (NVDA).

Company Calendar

• Record date for 7/15 Dividend: 6/13/2025
• Ex-Dividend for 7/15 Dividend: 6/13/2025
• Dividend Payable: 7/15/2025
• Last Earnings: 7/23/2025
• Today: 7/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:TMO
• CIK: 97745
• Web: www.thermofisher.com
• Phone: (781) 622-1000
• Fax: 781-622-1207
• Employees: 125,000
• Year Founded: 1956

Price Target and Rating

• Average Price Target for Thermo Fisher Scientific: $593.00
• High Price Target: $686.00
• Low Price Target: $470.00
• Potential Upside/Downside: +24.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 21 Analysts

Profitability

• EPS (Trailing Twelve Months): $17.29
• Trailing P/E Ratio: 27.59
• Forward P/E Ratio: 20.49
• P/E Growth: 2.58
• Net Income: $6.34 billion
• Net Margins: 15.24%
• Pretax Margin: 16.23%
• Return on Equity: 16.82%
• Return on Assets: 8.38%

Debt

• Debt-to-Equity Ratio: 0.65
• Current Ratio: 1.93
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: $42.88 billion
• Price / Sales: 4.20
• Cash Flow: $29.72 per share
• Price / Cash Flow: 16.05
• Book Value: $133.71 per share
• Price / Book: 3.57

Miscellaneous

• Outstanding Shares: 377,490,000
• Free Float: 376,248,000
• Market Cap: $180.07 billion
• Optionable: Optionable
• Beta: 0.77